Res-Q was developed by ThermoGenesis Corp. to compliment its MXP system.
Celling is also establishing Institutes of Regenerative Medicine to further research and develop therapies for adult stem cells.
Read Celling Technologies’ release on Res-Q.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
